Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)

SHA:605177 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	226.43	513.18	711.12	501.58	556.1	989.38
Short-Term Investments	-	-	177.9	-	-	-
Trading Asset Securities	150	50	-	30	50	-
Cash & Short-Term Investments	376.43	563.18	889.03	531.58	606.1	989.38
Cash Growth	28.05%	-36.65%	67.24%	-12.29%	-38.74%	642.63%
Accounts Receivable	113.44	178.1	209.59	159.39	128.89	114.7
Other Receivables	1.62	4.76	1.45	1.42	1.65	1.52
Receivables	115.06	182.85	211.03	160.81	130.54	116.22
Inventory	693.28	720.57	621.06	482.84	419.33	267.55
Prepaid Expenses	-	-	-	1.08	-	-
Other Current Assets	81.49	62.35	25.94	12.42	16.45	11.15
Total Current Assets	1,266	1,529	1,747	1,189	1,172	1,384
Property, Plant & Equipment	1,822	1,744	1,352	1,011	834.88	632.56
Long-Term Investments	50.3	119.28	150.64	181.46	10	-
Other Intangible Assets	60.09	60.06	61.85	62.97	45.15	46.56
Long-Term Deferred Tax Assets	51.22	32.89	12.53	12.9	10.52	6.76
Long-Term Deferred Charges	57.62	33.94	10.82	4.31	3.89	1.46
Other Long-Term Assets	77.82	37.09	8.59	10.5	174.21	9.72
Total Assets	3,386	3,557	3,343	2,472	2,251	2,081
Accounts Payable	419.62	731.77	520.12	411.09	406.25	267.9
Accrued Expenses	26.44	37.27	40.83	37.02	24.65	24.07
Short-Term Debt	261.42	98.94	120.07	95.01	-	10.01
Current Portion of Long-Term Debt	3.64	9.1	-	0.02	-	-
Current Portion of Leases	-	2.98	3.82	3.63	-	-
Current Income Taxes Payable	13.55	0	6.79	9.49	3.64	-
Current Unearned Revenue	15.4	10.36	3.23	8.41	9.41	5.92
Other Current Liabilities	22.63	23.13	3.19	5.02	5.34	5.84
Total Current Liabilities	762.71	913.55	698.05	569.69	449.29	313.74
Long-Term Debt	719.19	677.24	576.43	15	-	-
Long-Term Leases	6.13	4.8	6.62	9.1	2.38	-
Long-Term Unearned Revenue	84.54	85.84	46.2	36.71	40.47	36.74
Long-Term Deferred Tax Liabilities	0.29	0.16	0.46	0.67	-	-
Other Long-Term Liabilities	0.24	0.27	0.32	0.79	0.85	1.31
Total Liabilities	1,573	1,682	1,328	631.95	492.99	351.79
Common Stock	114.73	114.75	113.6	113.6	113.6	113.6
Additional Paid-In Capital	1,127	1,118	1,129	1,129	1,129	1,129
Retained Earnings	476.65	549.06	686.3	597.99	516.31	487.57
Treasury Stock	-20.29	-20.55	-30	-	-	-
Comprehensive Income & Other	114.53	113.18	116.72	-0.48	-0.48	-0.27
Total Common Equity	1,813	1,875	2,015	1,840	1,758	1,730
Minority Interest	-	0.12	-	-	-	-
Shareholders' Equity	1,813	1,875	2,015	1,840	1,758	1,730
Total Liabilities & Equity	3,386	3,557	3,343	2,472	2,251	2,081
Total Debt	990.39	793.06	706.93	122.76	2.38	10.01
Net Cash (Debt)	-613.96	-229.88	182.1	408.82	603.72	979.37
Net Cash Growth	-	-	-55.46%	-32.28%	-38.36%	764.96%
Net Cash Per Share	-5.42	-2.06	1.46	3.60	5.29	11.21
Filing Date Shares Outstanding	112.28	108.61	111.43	113.6	113.6	113.6
Total Common Shares Outstanding	112.28	108.61	112.58	113.6	113.6	113.6
Working Capital	503.55	615.4	1,049	619.04	723.13	1,071
Book Value Per Share	16.14	17.26	17.90	16.20	15.48	15.23
Tangible Book Value	1,753	1,815	1,953	1,777	1,713	1,683
Tangible Book Value Per Share	15.61	16.71	17.35	15.64	15.08	14.82
Buildings	-	632.03	545.94	454.64	410.59	348.42
Machinery	-	1,189	1,084	878.92	723.64	515.13
Construction In Progress	-	599.8	296.55	157.09	114.87	138.63

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.